UB Paderborn / Katalog / Suche / in CDI

Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses

mBio, 2021-12, Vol.12 (6), p.e0334721

2021

Link zum Volltext

Verfügbarkeit prüfen

Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition

PloS one, 2022-05, Vol.17 (5), p.e0267729-e0267729

2022

Link zum Volltext

Verfügbarkeit prüfen

Factors Associated With Severity of COVID-19 Disease in a Multicenter Cohort of People With HIV in the United States, March-December 2020

Journal of acquired immune deficiency syndromes (1999), 2022-08, Vol.90 (4), p.369

2022

Link zum Volltext

Verfügbarkeit prüfen

New skin lesions in a liver transplant recipient

American journal of transplantation, 2019-10, Vol.19 (10), p.2955-2957

2019

Link zum Volltext

Verfügbarkeit prüfen

HIV Disease Dynamics and Markers of Inflammation and CNS Injury During Primary HIV Infection and Their Relationship to Cognitive Performance

Journal of acquired immune deficiency syndromes (1999), 2022-02, Vol.89 (2), p.183

2022

Link zum Volltext

Verfügbarkeit prüfen

Initiation of Antiretroviral Therapy during Primary HIV Infection: Effects on the Latent HIV Reservoir, Including on Analytic Treatment Interruptions

AIDS reviews, 2020-10, Vol.23 (1), p.28-39

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS‐CoV‐2 Infection

Clinical pharmacology and therapeutics, 2022-12, Vol.112 (6), p.1207-1213

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of Antiretroviral Therapy on Cancer Treatment Outcomes among People Living with HIV in Low- and Middle-Income Countries: a Systematic Review

Current HIV/AIDS reports, 2021-04, Vol.18 (2), p.105-116

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study

The Lancet. Microbe, 2021-05, Vol.2 (5), p.e198-e209

2021

Link zum Volltext

Verfügbarkeit prüfen

Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial

The Journal of infectious diseases, 2015-12, Vol.212 (12), p.1949-1956

2015

Link zum Volltext

Verfügbarkeit prüfen

Characterizing HIV status documentation among cancer patients at regional cancer centers in Malawi, Zimbabwe, and South Africa

Infectious agents and cancer, 2023-10, Vol.18 (1), p.65-65, Article 65

2023

Link zum Volltext

Verfügbarkeit prüfen

Dynamic immune markers predict HIV acquisition and augment associations with sociobehavioral factors for HIV exposure

iScience, 2022-12, Vol.25 (12), p.105632-105632, Article 105632

2022

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive viromewide antibody responses by systematic epitope scanning after hematopoietic cell transplantation

Blood, 2019-08, Vol.134 (6), p.503-514

2019

Link zum Volltext

Verfügbarkeit prüfen

Protocol for evaluating mechanistic pathways associated with HIV acquisition via nested Least Absolute Shrinkage and Selective Operator analysis

STAR protocols, 2023-12, Vol.4 (4), p.102628-102628, Article 102628

2023

Link zum Volltext

Verfügbarkeit prüfen

Strategies for Expediting Clinical Trials in the Next Public Health Emergency

JAMA health forum, 2023-09, Vol.4 (9), p.e233191-e233191

2023

Link zum Volltext

Verfügbarkeit prüfen

Evolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trials

Journal of the National Comprehensive Cancer Network, 2018-08, Vol.16 (8), p.1018

2018

Link zum Volltext

Verfügbarkeit prüfen

A Population‐based Study of Perinatal Infection Risk in Women with and without Systemic Lupus Erythematosus and their Infants

Paediatric and perinatal epidemiology, 2018-01, Vol.32 (1), p.81-89

2018

Link zum Volltext

Verfügbarkeit prüfen

Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19

The Lancet infectious diseases, 2022-05, Vol.22 (5), p.567-569

2022

Link zum Volltext

Verfügbarkeit prüfen

HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru

Journal of the International AIDS Society, 2019-11, Vol.22 (11), p.e25411-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial

Open forum infectious diseases, 2023-08, Vol.10 (8), p.ofad419-ofad419

2023

Link zum Volltext

Verfügbarkeit prüfen

T Cell Immunity to Varicella-Zoster Virus in the Setting of Advanced HIV and Multiple Varicella-Zoster Virus Recurrences

Viral immunology, 2017-01, Vol.30 (1), p.77

2017

Link zum Volltext

Verfügbarkeit prüfen

Hemophagocytic Lymphohistiocytosis Secondary to Human Immunodeficiency Virus-Associated Histoplasmosis

Open forum infectious diseases, 2015-12, Vol.2 (4), p.ofv140-ofv140

2015

Link zum Volltext

Verfügbarkeit prüfen

COVID-19: Where We Are, Where We Need to Be

Infectious disease clinics of North America, 2022-06, Vol.36 (2), p.xiii

2022

Link zum Volltext

Verfügbarkeit prüfen

Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19

Open forum infectious diseases, 2022-11, Vol.9 (11), p.ofac618-ofac618

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses

Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition

Factors Associated With Severity of COVID-19 Disease in a Multicenter Cohort of People With HIV in the United States, March-December 2020

New skin lesions in a liver transplant recipient

HIV Disease Dynamics and Markers of Inflammation and CNS Injury During Primary HIV Infection and Their Relationship to Cognitive Performance

Initiation of Antiretroviral Therapy during Primary HIV Infection: Effects on the Latent HIV Reservoir, Including on Analytic Treatment Interruptions

Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS‐CoV‐2 Infection

Impact of Antiretroviral Therapy on Cancer Treatment Outcomes among People Living with HIV in Low- and Middle-Income Countries: a Systematic Review

Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study

Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial

Characterizing HIV status documentation among cancer patients at regional cancer centers in Malawi, Zimbabwe, and South Africa

Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States

Dynamic immune markers predict HIV acquisition and augment associations with sociobehavioral factors for HIV exposure

Comprehensive viromewide antibody responses by systematic epitope scanning after hematopoietic cell transplantation

Protocol for evaluating mechanistic pathways associated with HIV acquisition via nested Least Absolute Shrinkage and Selective Operator analysis

Strategies for Expediting Clinical Trials in the Next Public Health Emergency

Evolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trials

A Population‐based Study of Perinatal Infection Risk in Women with and without Systemic Lupus Erythematosus and their Infants

Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19

HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru

The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial

T Cell Immunity to Varicella-Zoster Virus in the Setting of Advanced HIV and Multiple Varicella-Zoster Virus Recurrences

Hemophagocytic Lymphohistiocytosis Secondary to Human Immunodeficiency Virus-Associated Histoplasmosis

COVID-19: Where We Are, Where We Need to Be

Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19

Suchergebnisse filtern